Journal Article Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation

Takamatsu, Hiroyuki  ,  Araki, Raita  ,  Nishimura, Ryosei  ,  Yachie, Akihiro  ,  Espinoza, J. Luis  ,  Okumura, Hirokazu  ,  Yoshida, Takashi  ,  Kuzushima, Kiyotaka  ,  Nakao, Shinji

80pp.82 - 86 , 2016-06-01 , Elsevier
ISSN:1386-6532
NCID:AA11281494
Description
Leukemic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative diseases (PTLD) following allogeneic hematopoietic stem cell transplantation are extremely rare. We can successfully treat an EBV-associated leukemic lymphoma patient with rituximab, cidofovir, and donor lymphocyte infusion (DLI). In the present case, EBV-specific T cells that were present in the peripheral blood before rituximab administration treatment rapidly increased after DLI in association with a decrease in the EBV-DNA load. © 2016 Elsevier B.V.
Full-Text

http://dspace.lib.kanazawa-u.ac.jp/dspace/bitstream/2297/45519/1/ME-PR-TAKAMATSU-H-82.pdf

Number of accesses :  

Other information